Skip to main content

Brovana Side Effects

Generic name: arformoterol

Medically reviewed by Drugs.com. Last updated on Oct 19, 2023.

Note: This document contains side effect information about arformoterol. Some dosage forms listed on this page may not apply to the brand name Brovana.

Applies to arformoterol: inhalation solution.

Serious side effects of Brovana

Along with its needed effects, arformoterol (the active ingredient contained in Brovana) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking arformoterol:

More common

Less common

Get emergency help immediately if any of the following symptoms of overdose occur while taking arformoterol:

Symptoms of overdose

Other side effects of Brovana

Some side effects of arformoterol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to arformoterol: inhalation solution.

Respiratory

Common (1% to 10%): Dyspnea, sinusitis, flu syndrome, pulmonary and chest congestion

Frequency not reported (Less than 2%): Respiratory disorder, voice alteration[Ref]

Two double-blind, placebo-controlled clinical trials showed a decreased or comparable incidence of COPD exacerbations when compared to placebo. COPD exacerbations occurred at a rate of 12.1% for those patients receiving the drug and 15.1% for those patients receiving placebo.[Ref]

Cardiovascular

Common (1% to 10%): Chest pain, peripheral edema

Frequency not reported (Less than 2%): Arteriosclerosis, atrial flutter, AV block, congestive heart failure, heart block, myocardial infarct, QT interval prolongation, supraventricular tachycardia, inverted T-wave[Ref]

Two double-blind, placebo-controlled clinical trials showed a decreased or comparable incidence of cardiovascular events. Frequency of all cardiovascular events was 6.9% in those using the drug and 13.3% in the placebo group. No frequently occurring, defined as 1% or greater than placebo, cardiovascular events were associated.[Ref]

Dermatologic

Common (1% to 10%): Rash

Frequency not reported (Less than 2%): Dry skin, herpes simplex, herpes zoster, skin discoloration, skin hypertrophy[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea

Frequency not reported (Less than 2%): Constipation, gastritis, melena, oral moniliasis, periodontal abscess, rectal hemorrhage[Ref]

Musculoskeletal

Common (1% to 10%): Back pain, leg cramps

Frequency not reported (Less than 2%): Neck rigidity, pelvic pain, arthralgia, arthritis, rheumatoid arthritis, bone disorder, tendinous contracture[Ref]

Hematologic

Frequency not reported (Less than 2%): Retroperitoneal hemorrhage

Hypersensitivity

Frequency not reported (Less than 2%): Allergic reaction

Local

Frequency not reported (Less than 2%): Injection site pain

Metabolic

Frequency not reported (Less than 2%): Dehydration, edema, glucose tolerance decreased, gout, hyperglycemia, hyperlipidemia, hypoglycemia, hypokalemia

Nervous system

Frequency not reported (Less than 2%): Agitation, cerebral infarct, circumoral paresthesia, hypokinesia, somnolence, tremor, paralysis

Ocular

Frequency not reported (Less than 2%): Abnormal vision, glaucoma

Oncologic

Frequency not reported (Less than 2%): Neoplasm, carcinoma of the lung, breast neoplasm

Other

Common (1% to 10%): Pain

Frequency not reported (Less than 2%): Digitalis intoxication, abscess, fever, hernia

Genitourinary

Frequency not reported (Less than 2%): Calcium crystalluria, cystitis, glycosuria, hematuria, kidney calculus, nocturia, PSA increase, pyuria, urinary tract disorder, urine abnormality

References

1. Product Information. Brovana (arformoterol). Sepracor Inc. 2006.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.